Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 156.71 | 159.62 | 161.11 | 122.67 |
Total Revenue | 156.71 | 159.62 | 161.11 | 122.67 |
Costof Revenue Total | 120.81 | 128.06 | 130.46 | 96.59 |
Gross Profit | 35.90 | 31.57 | 30.65 | 26.08 |
Selling/ General/ Admin Expenses Total | 5.13 | 4.96 | 5.07 | 4.04 |
Depreciation/ Amortization | 1.99 | 1.94 | 1.70 | 1.22 |
Unusual Expense( Income) | 0.09 | -0.23 | - | - |
Other Operating Expenses Total | 17.47 | 16.69 | 14.30 | 12.21 |
Total Operating Expense | 145.49 | 151.42 | 151.51 | 114.07 |
Operating Income | 11.22 | 8.21 | 9.59 | 8.60 |
Interest Inc( Exp) Net- Non- Op Total | -49.15 | -27.37 | -16.80 | -31.76 |
Other Net | 0.62 | -0.53 | -0.89 | 0.28 |
Net Income Before Taxes | 6.92 | 4.93 | 7.02 | 5.71 |
Provisionfor Income Taxes | 1.37 | 1.15 | 1.78 | 1.58 |
Net Income After Taxes | 5.55 | 3.79 | 5.25 | 4.13 |
Net Income Before Extra Items | 5.55 | 3.79 | 5.25 | 4.13 |
Net Income | 5.55 | 3.79 | 5.25 | 4.13 |
Income Availableto Com Excl Extra Ord | 5.55 | 3.79 | 5.25 | 4.13 |
Income Availableto Com Incl Extra Ord | 5.55 | 3.79 | 5.25 | 4.13 |
Diluted Net Income | 5.55 | 3.79 | 5.25 | 4.13 |
Diluted Weighted Average Shares | 0.75 | 0.75 | 0.75 | 0.75 |
Diluted EPS Excluding Extra Ord Items | 7.37 | 5.03 | 6.97 | 5.48 |
Diluted Normalized EPS | 7.47 | 4.80 | 6.97 | 5.48 |
Godavari Drugs Dividend Godavari Drugs Bonus Godavari Drugs News Godavari Drugs AGM Godavari Drugs Rights Godavari Drugs Splits Godavari Drugs Board Meetings Godavari Drugs Key Metrics Godavari Drugs Shareholdings Godavari Drugs Balance Sheet Godavari Drugs Cashflow Godavari Drugs Q1 Results Godavari Drugs Q2 Results Godavari Drugs Q3 Results Godavari Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks